Patient P-02662
Synthetic patientMETA-24 · Day 101 · 65–74 · M · baseline S01Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
45%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S01
- Day 23 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 23.
Primary contributors, last 14 days
- Nutritional resilience-18
- GI instability+15
- Inflammatory activity+10
- Treatment adherence-7
- Toxicity+2
What helped?
No interventions yet.
LIFE OS recommendation
Dietary Support Protocol NP-02
30%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 0% showed improvement
- median effect visible after 10 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable73 min
worsening · -4.2 vs previous 14 d
Sleep duration
Wearable6.6 h
stable · +0.1 vs previous 14 d
Energy level
Daily log5.1/10
worsening · -0.4 vs previous 14 d
Steps
Wearable7,515
worsening · -578 vs previous 14 d
GI burden
Companion37.2/100
worsening · +5.8 vs previous 14 d
Adherence
Companion77.5 %
worsening · -4.5 vs previous 14 d
Sleep quality
Wearable42.7/100
stable · +0.2 vs previous 14 d
Glucose, CGM daily mean
CGM135 mg/dL
stable · +4.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 46 from the failing basin, 63 from restoration.
Would help
- NP-02 Dietary Support Protocol80% improved among 5 similar · onset 10 d · confidence 53%
- More proteinGI -5.7 next day on high-intake days · n 20
Would not help
- BR-03 Behavioural Recommendationonly 27% improved among 11 similar
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.7supporter · 95%
- Dietary fat load+2no signal · 31%
- Simple carbohydrates-2no signal · 27%
- Alcohol-1.9no signal · 34%
- Ultra-processed food+1.9no signal · 31%
- Caffeine+0.5no signal · 15%
- Histamine load-0.4no signal · 15%
- Insoluble fibre-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.7 · butyrate capacity 54/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 51 ms
- Sleep
- 6.9 h
- Steps
- 8,149
- Resting HR
- 57 bpm
Daily log: GI score 37, nutritional resilience 52, adherence 78.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.